## TEAM: Atlassian Corporation - XLK: Technology

### Executive Summary

No thesis match: PEG 1.70 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($152.54)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-18 | Bernstein | $304 | $290 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-18 | Bernstein | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 19 ($0.58M) |
| Sells | 130 ($32.32M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.0% (+6.0%)
- Blackrock Inc.: 6.3% (-1.4%)
- BAILLIE GIFFORD & CO: 4.8% (-4.8%)
- JPMORGAN CHASE & CO: 2.9% (+22.6%)
- State Street Corpora: 2.3% (+1.9%)

### Key Risks

1. Volume divergence: price rising (+2.1% MRS) on declining volume (68% of avg) suggests distribution.
2. Heavy insider selling: $32M sold (130 transactions in 90 days).
3. Long-term trend broken: trading 13.8% below SMA200.

### Catalysts

- Momentum building: MRS_20 improving +2.1% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.70 elevated, pricing in significant growth expectations. Insider selling cluster ($32.3M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $43.0B |
| Beta | 0.90 |
| 52W Range | $139.70 - $326.00 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.70 |
| Forward P/E | 29.0 |
| Current P/E | 33.5 |
| YoY Growth | 15.4% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 2.6% to 4.7% (+2.1% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 74th percentile. MRS_5 at 1.2% confirms short-term momentum alignment. AM_20 at 6.9% shows strong absolute momentum above own 20MA. Outperforming sector by 3.5pp, stock-specific strength. Below SMA200 (0.86x), long-term trend not supportive. MACD histogram positive (1.81), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.69% (CS: 75) | Strong |
| RSI_14 | 62.7 | Neutral |
| MACD Histogram | 1.81 | Bullish |
| vs SMA20 | 1.069x | Above |
| vs SMA50 | 1.049x | Above |
| vs SMA200 | 0.862x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $163.26
- **Stop Loss:** $152.54 (6.6% risk)
- **Target:** $173.98 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 128
- **Position Value:** $20,897.28
- **Portfolio %:** 20.90%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-29 (Est: $1.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.84 | $1.04 | +24.1% |
| 2025Q2 | $0.85 | $0.98 | +14.6% |
| 2025Q1 | $0.93 | $0.97 | +4.8% |
| 2024Q4 | $0.76 | $0.96 | +27.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*